Robert J Omeljaniuk

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

Palliative Care

Anterior Cruciate Ligament

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Ramona Meanti, Martina Licata, Laura Rizzi, Elena Bresciani, Laura Molteni, Silvia Coco, Vittorio Locatelli, Robert J Omeljaniuk, Antonio Torsello
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein. International journal of molecular sciences 24 (2) (2023)
Ramona Meanti, Martina Licata, Laura Rizzi, Elena Bresciani, Laura Molteni, Silvia Coco, Vittorio Locatelli, Robert J Omeljaniuk, Antonio Torsello
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein. International journal of molecular sciences 24 (2) (2023)
Ramona Meanti, Martina Licata, Laura Rizzi, Elena Bresciani, Laura Molteni, Silvia Coco, Vittorio Locatelli, Robert J Omeljaniuk, Antonio Torsello
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein. International journal of molecular sciences 24 (2) (2023)
Ramona Meanti, Martina Licata, Laura Rizzi, Elena Bresciani, Laura Molteni, Silvia Coco, Vittorio Locatelli, Robert J Omeljaniuk, Antonio Torsello
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein. International journal of molecular sciences 24 (2) (2023)
Laura Rizzi, Marco Turati, Elena Bresciani, Filippo Maria Anghilieri, Ramona Meanti, Laura Molteni, Massimiliano Piatti, Nicolò Zanchi, Silvia Coco, Francesco Buonanotte, Luca Rigamonti, Giovanni Zatti, Vittorio Locatelli, Robert J Omeljaniuk, Marco Bigoni, Antonio Torsello
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears. Biomedicines 10 (11) (2022)